NCT07002905 A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities Status COMPLETED Phase PHASE2
NCT06972992 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide Status COMPLETED Phase PHASE1
NCT06703021 A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity Status COMPLETED Phase PHASE2
NCT06679959 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06671821 Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects Status COMPLETED Phase PHASE2
NCT06427590 A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects Status COMPLETED Phase PHASE1
NCT01987427 A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults Status COMPLETED Phase PHASE4